Seoul High Court dismisses appeal over Dongsung Pharmaceutical rehabilitation plan

Seoul High Court dismissed an immediate appeal against approval of Dongsung Pharmaceutical’s rehabilitation plan on Sept. 30, 2026, upheld the first-instance decision and ordered appeal costs.